iRadimed Inc. IPO Advisory
Share this IPO Profile:
Smart Search
For IPO Boutique's "scale of 1 to 5" BUY rating on iRadimed Inc., and our comprehensive analysis, click "
Buy Market Research".
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| iRadimed Inc. | IRMD - NASDAQ |
$5.00-$6.00 |
$6.25 |
$10.00 | 2.02 million | 7/16/2014 |
| Roth Capital Partners |
Co-Manager(s): Monarch Capital Group |
| Health Care |
Filing(s):
Filed 2014-06-19
Terms Added 2014-07-09
|
iRadimed Inc. Quote & Chart - Click for current quote -
IRMD
About iRadimed Inc. (adapted from iRadimed Inc. prospectus):
They are the leading provider of non-magnetic intravenous ('IV') infusion pump systems that are safe for use during magnetic resonance imaging ('MRI') procedures.
This description is adapted from Iradimed Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Iradimed Inc. "IRMD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2025 IPO Boutique. All Rights Reserved
